You are here

Prices & Quotes - UK Markets - Renalytix (Reg S) (RENX)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 685.00p
Change Today:
-5.00p
Market Cap:
495.32m
Sector:
Health Care Equipment & Services

Renalytix appoints Ann Berman to board

By Josh White

Date: Wednesday 28 Jul 2021

LONDON (ShareCast) - (Sharecast News) - Renalytix announced the appointment of Ann Berman to its board on Wednesday, as chair of its audit committee and a member of the nomination committee.
The AIM-traded firm said Berman currently served on the board of directors and as a member of the audit committee of Loews Corporation.

In addition, she is a member of the board of trustees of Beth Israel Deaconess Medical Center, where she is the chair of the compliance and risk committees, and Immuneering Corporation, where she chairs the audit committee.

"We are delighted to have a professional of Ann's capabilities on board as Renalytix enters into a substantial growth phase," said interim chairman Christopher Mills.

"Her leadership and operational experience will be invaluable to helping us drive shareholder value."

Before her retirement in 2009, Berman served as chief financial officer of Harvard University, where she was responsible for financial strategy, policy and planning, financial reporting and operations, treasury and risk management, and various audit functions.

As part of her role, she served on the board of Harvard Management Company, the investment management firm for Harvard University's endowment.

Before joining Harvard, Berman was a partner with Richard A. Eisner & Co, an accounting firm, from 1978 to 1985, having began her career in finance at Price Waterhouse.

She is a certified public accountant who is qualified as a financial expert for audit committee leadership, with extensive experience overseeing audit-related matters, enterprise risk management, internal audit, cybersecurity, and compliance.

Berman earned a B.A. in French language and literature at Cornell University, Phi Beta Kappa, and an M.B.A. with a concentration in accounting from the University of Pennsylvania's Wharton School of Business.

"Renalytix is doing important and exciting work in improving the care and treatment of kidney disease," said Ann Berman.

"I am very pleased to contribute my expertise to advancing the company and supporting its goals."

At 1021 BST, shares in Renalytix AI were up 0.91% at 1,105p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

RENX Market Data

Currency UK Pounds
Price 685.00p
Change Today -5.00p
52 Week High 1,220.00p
52 Week Low 460.00p
Volume 36,392
Shares Issued 72.31m
Market Cap 495.32m
Beta 0.72

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Income
Not Available
Growth
Not Available
Price Chg 6m
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. full market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. half sector star
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector

RENX Dividends

No dividends found

Trades for 29-Nov-2021

Time Volume / Share Price
15:15 5,000 @ 700.00p
16:09 1,216 @ 700.00p
15:32 100 @ 694.00p
14:41 109 @ 687.55p
14:09 500 @ 685.00p

RENX Key Personnel

CEO James Renwick McCullough
CFO James Sterling